文献速递妇科生殖医学

浆液黏液性交界性卵巢肿瘤患者保留生育功能手术后的肿瘤学和生殖结局:一项大型回顾性研究结果

Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
PubMed 文献 · Gynecol Oncol · 2022-04-22

该回顾性研究纳入2000至2019年间接受手术的105例浆液黏液性交界性卵巢肿瘤患者,其中65例接受保留生育功能手术(FSS),40例接受根治性手术(RS)。中位随访59.6个月,两组无病生存期无显著差异(P=0.141);多因素分析显示仅双侧受累与复发增加相关(P=0.008)。FSS组12例复发者中11例再次接受FSS,末次随访均无瘤存活;20例有生育意愿者中16例成功,共获17次足月分娩。

要点

  • FSS组与RS组无病生存期无显著差异(P=0.141)。
  • 多因素分析显示仅双侧受累与复发增加相关(P=0.008)。
  • FSS组12例复发者中11例再次FSS后均无瘤存活。

核心结论

  • FSS对于希望保留生育功能的年轻患者是可行的。
  • 初次接受卵巢囊肿剔除术的患者,若术后影像学阴性,可进行密切监测。
  • 经过充分沟通后,重复FSS仍是复发性SMBOT年轻患者的有价值选择。

研究设计与样本

  • 回顾性研究,纳入2000至2019年间接受手术的105例浆液黏液性交界性卵巢肿瘤患者。
  • 65例接受保留生育功能手术(FSS),40例接受根治性手术(RS)。
  • 进行了集中组织学审查,并比较不同手术方式的复发率。

主要发现

  • 中位随访59.6个月(范围22.1-256.8个月),14例患者复发,除1例外均复发为SMBOT。
  • FSS组与RS组无病生存期无显著差异(P=0.141)。
  • 多因素分析显示仅双侧受累与复发增加相关(P=0.008)。
  • 在保守手术亚组中,卵巢囊肿剔除术与输卵管卵巢切除术的无病生存期无显著差异(P=0.487)。
  • FSS组12例复发患者中11例接受第二轮FSS,末次随访均无瘤存活;20例有生育意愿者中16例成功,获17次足月分娩。

临床怎么用

  • 作者认为FSS对于希望保留生育功能的年轻患者是可行的。
  • 作者认为初次接受卵巢囊肿剔除术的患者,若术后影像学阴性,可进行密切监测。
  • 作者认为经过充分沟通后,重复FSS仍是复发性SMBOT年轻患者的有价值选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the oncological and reproductive outcomes in patients with seromucinous borderline ovarian tumors (SMBOT) treated with fertility-sparing surgery (FSS). METHODS: We retrospectively reviewed the medical records of patients with SMBOT who underwent surgery between 2000 and 2019. A centralized histological review was performed and recurrence rates were compared between different surgical procedures. RESULTS: A total of 105 patients fulfilled the inclusion criteria, of whom 65 underwent FSS and 40 were treated with radical surgery (RS). Fourteen patients had recurrent disease after a median follow-up time of 59.6 months (range: 22.1-256.8 months). All but one relapsed with SMBOT. There was no significant difference in disease-free survival (DFS) between the two groups (P = 0.141). Multivariate analysis showed that only bilateral involvement was associated with increased recurrence (P = 0.008). In the subgroup of patients treated with conservative surgery, there was no significant difference in DFS with regard to surgical procedures (ovarian cystectomy vs salpingo-oophorectomy, P = 0.487). Of the 12 patients in the FSS group who developed recurrence, 11 underwent a second round of FSS and all remained alive with no evidence of disease at the end of follow-up. Of 20 patients desiring pregnancy, 16 patients were successful and resulted in 17 term deliveries. CONCLUSIONS: FSS is feasible for young patients who wish to preserve their fertility. Patients initially treated with ovarian cystectomy may be managed by close surveillance if post-operative imaging are negative. Repeat FSS remains a valuable alternative for young patients with recurrent SMBOT after thorough communication.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wang D, Jia S, Jia C, et al. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study. Gynecol Oncol. 2022. PMID: 35469684. doi:10.1016/j.ygyno.2022.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。